Ｔ細胞療法 - Kite Pharma, Inc

Title:

Ｔ細胞療法

Document Type and Number:

Japanese Patent JP2024502599

Kind Code:

A

Abstract:

本開示は、診断及び予後診断の方法、免疫療法のための組成物、当該組成物を改善する方法、及びそれを使用する免疫療法に関する。

More Like This:

JP2602517	[Title of the invention] Isolation method of novel viral factor derived from non-A non-B hepatitis and antigen bound thereto, viral factor and antigen obtained by this method, method of detecting this antigen, and non-A non-B viral property. Immunogen for hepatitis detection, its manufacturing method and application
WO/2014/210481	POROUS POLYMERIC FORMULATION PREPARED USING POROGENS
JP2002542488	INDUSTRIAL APPLICABILITY Peptide epitopes recognized by CD4 + T lymphocytes that promote disease

Inventors:

Bot Adrian Ai.
Booka Justin
Chow Zu-ting
Miletti Francisca
Prax Vicky
Rossi John Em.

Application Number:

JP2023541537A

Publication Date:

January 22, 2024

Filing Date:

January 07, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Kite Pharma, Inc

International Classes:

G01N33/53; A61K31/337; A61K31/513; A61K31/675; A61K31/704; A61K31/7068; A61K35/17; A61K39/395; A61K45/00; A61P35/00; A61P37/02; A61P43/00; C07K16/28; C07K19/00; C12N5/0786; C12N5/10

Attorney, Agent or Firm:

Saegusa International Patent Office

Previous Patent: Oral administration of ketamine

Next Patent: vibration damping acoustic array